Fat Based Stem Cell Technology Moving to Clinical Trials Without Utilizing Human Embryonic Stem Cells

Healtheuniverse, Inc. has announced that the Company's fat based stem cell technology is moving to clinical trials without the use of human embryonic stem cells.

The Company is preparing to submit an application through an Independent Institutional Review Board to pursue clinical trial for the utilization of fat based stem cells.

Using this approach provides the promise of stem cell medical achievements while avoiding the controversy surrounding destruction of embryos.

Adipose tissue, also known as fat, is an abundant source of stem cells and other regenerative cells that can contribute to the repair and healing of damaged tissue.

Clinical trials will be focused on growing different cell types from adult stem cells utilizing a proprietary process.

Therapies utilizing this process have varied applications for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery.

The clinical trials using adult stem cells are important because they provide the promise of significant medical advancement in the stem cell field while avoiding the controversy of using stem cells from embryos.

Dr. Vipul Dev, M.D. PhD., CEO of Healtheuniverse, Inc. and Plastic and Reconstructive Surgeon, stated, "Fat tissue has the potential to be grown for plastic and reconstructive cases performed daily in our clinics in California."

"The engineered tissue can initially be used to repair facial deformities, breast reconstruction, and various defects caused by disease or trauma."

"Our patients would benefit greatly from a customized tissue replacement engineered from their own fat tissue."

"Significant benefits from these techniques include no negative immune responses since the replacement tissue is from the patient's own cells."